This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
FEMININE PAIN RELIEF — Description, Dosage, Side Effects | PillsCard
OTC
FEMININE PAIN RELIEF
200 mg/1, Patch
INN: MENTHOL, UNSPECIFIED FORM
Data updated: 2026-05-02
Available in:
🇩🇪🇬🇧
Form
PATCH
Dosage
200 mg/1
Route
TOPICAL
Storage
—
About This Product
Manufacturer
Unexo Life Sciences, Private Limited
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Source
OPENFDA_NDC
Kyrle diseaseis identified as a form of an acquired perforating disease. Other major perforating diseases areelastosis perforans serpiginosaandreactive perforating collagenosis. Recently, however, there is a controversy on categorizing Kyrle disease with perforatingdermatosisor a subtype ofacquired perforating collagenosis.
Kyrle disease was first described byJosef Kyrlein 1916 when a diabetic woman presented generalizedhyperkeratoticnodules.The disease is distinguished by large papules with centralkeratinplug on the skin, usually on the legs of the patient and is often in conjunction withliver,kidneyor diabetic disorders. It can affect both females and males with a 6:1 ratio. The papules usually show up on the patient with an average age of 30 years.Kyrle disease is a rare disease unless there is a high count of patients with chronickidney failure. The disease seems to be more prevalent in African Americans, which can be correlated to the high incidence ofdiabetes mellitusandkidney failurein the population.